|
1
|
Reversal of human cellular senescence: roles of the p53 and p16 pathways.
|
EMBO J
|
2003
|
5.61
|
|
2
|
In situ analyses of genome instability in breast cancer.
|
Nat Genet
|
2004
|
4.32
|
|
3
|
A versatile viral system for expression and depletion of proteins in mammalian cells.
|
PLoS One
|
2009
|
3.83
|
|
4
|
ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium.
|
Proc Natl Acad Sci U S A
|
2012
|
2.20
|
|
5
|
Identification of genes directly regulated by the oncogene ZNF217 using chromatin immunoprecipitation (ChIP)-chip assays.
|
J Biol Chem
|
2007
|
1.88
|
|
6
|
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition.
|
J Exp Med
|
2012
|
1.85
|
|
7
|
Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer.
|
Cancer Res
|
2006
|
1.69
|
|
8
|
Cancer and aging: the importance of telomeres in genome maintenance.
|
Int J Biochem Cell Biol
|
2005
|
1.64
|
|
9
|
Telomerase activation by c-Myc in human mammary epithelial cells requires additional genomic changes.
|
Cell Cycle
|
2009
|
1.52
|
|
10
|
Human epithelial cell immortalization as a step in carcinogenesis.
|
Cancer Lett
|
2003
|
1.38
|
|
11
|
Specific recognition of ZNF217 and other zinc finger proteins at a surface groove of C-terminal binding proteins.
|
Mol Cell Biol
|
2006
|
1.36
|
|
12
|
Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion.
|
Oncogene
|
2002
|
1.32
|
|
13
|
Amplification of zinc finger gene 217 (ZNF217) and cancer: when good fingers go bad.
|
Biochim Biophys Acta
|
2007
|
1.27
|
|
14
|
ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction.
|
Hum Mol Genet
|
2005
|
1.25
|
|
15
|
p53-dependent integration of telomere and growth factor deprivation signals.
|
Proc Natl Acad Sci U S A
|
2007
|
1.18
|
|
16
|
Raf-induced MMP9 disrupts tissue architecture of human breast cells in three-dimensional culture and is necessary for tumor growth in vivo.
|
Genes Dev
|
2010
|
1.14
|
|
17
|
Loss of p53 function accelerates acquisition of telomerase activity in indefinite lifespan human mammary epithelial cell lines.
|
Oncogene
|
2003
|
1.13
|
|
18
|
Multidimensional profiling of cell surface proteins and nuclear markers.
|
IEEE/ACM Trans Comput Biol Bioinform
|
2010
|
1.13
|
|
19
|
The specific role of pRb in p16 (INK4A) -mediated arrest of normal and malignant human breast cells.
|
Cell Cycle
|
2012
|
1.10
|
|
20
|
Interaction of E-cadherin and PTEN regulates morphogenesis and growth arrest in human mammary epithelial cells.
|
Cancer Res
|
2009
|
1.08
|
|
21
|
The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression.
|
Cancer Discov
|
2012
|
1.06
|
|
22
|
Aging and cancer cell biology, 2009.
|
Aging Cell
|
2009
|
1.04
|
|
23
|
Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.03
|
|
24
|
Accumulation and altered localization of telomere-associated protein TRF2 in immortally transformed and tumor-derived human breast cells.
|
Oncogene
|
2005
|
0.89
|
|
25
|
p16(INK4a) -mediated suppression of telomerase in normal and malignant human breast cells.
|
Aging Cell
|
2010
|
0.88
|
|
26
|
BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas.
|
PLoS One
|
2010
|
0.88
|
|
27
|
Promotion of variant human mammary epithelial cell outgrowth by ionizing radiation: an agent-based model supported by in vitro studies.
|
Breast Cancer Res
|
2010
|
0.88
|
|
28
|
Crystal structure of human calmodulin-like protein: insights into its functional role.
|
FEBS Lett
|
2002
|
0.85
|
|
29
|
Who is in the driver's seat in 8p12 amplifications? ZNF703 in luminal B breast tumors.
|
Breast Cancer Res
|
2011
|
0.84
|
|
30
|
Soothing the watchman: telomerase reduces the p53-dependent cellular stress response.
|
Cell Cycle
|
2007
|
0.83
|
|
31
|
Synthetic and mechanistic pathways of cis and trans-hydroxytamoxifen drug derivatives reacting with Cp*Rh complexes that involve η1-N, η2-N,O, η1-O, and η6 bonding modes, via a novel N-π rearrangement; relative binding affinities and computer docking studies of cis and trans-η6-Cp*Rh-hydroxytamoxifen complexes at the estrogen, ERα and ERβ receptors, and growth inhibition to breast cancer cells.
|
Inorg Chem
|
2010
|
0.77
|
|
32
|
Parabens and Human Epidermal Growth Factor Receptor Ligand Cross-Talk in Breast Cancer Cells.
|
Environ Health Perspect
|
2015
|
0.75
|